Everolimus-Associated Cutaneous Toxicity: A CaseInsight
Title: Expanding the Spectrum of Everolimus-Associated Cutaneous Toxicity
Presenter: Reid Gordon
Affiliation: Wayne State University School of Medicine
Designation: Medical Student
Presentation Type: Oral Presentation
🧠 Understanding the Research Focus
This case
study highlights the clinical variability of everolimus-associated skin
toxicity, emphasizing the importance of recognizing atypical dermatological
reactions in oncology patients receiving mTOR inhibitors.
📊 Case Study Approach
An
elderly patient with renal cell carcinoma developed a distinctive pruritic
rash following everolimus therapy. Clinical evaluation and treatment
withdrawal confirmed the drug-related dermatologic reaction.
🔬 Clinical Findings
The
patient exhibited eczematous and maculopapular eruptions with a unique
dermatomal pattern. Rapid improvement after discontinuation of Everolimus
supported diagnosis and highlighted reversibility.
🎯 Key Takeaway Strategy
This
study emphasizes the need for early recognition, accurate diagnosis, and
proper management of drug-induced skin toxicities to improve patient care
in dermato-oncology.
👨⚕️
About the Author
Reid Gordon is a third-year medical student at Wayne State
University School of Medicine with a strong interest in dermatology. He holds a
background in mathematical sciences and focuses on advancing equitable
dermatologic care, including gender-affirming dermatology and improving
outcomes in skin of color populations.
🌍 Conference Details
Global Clinical & Aesthetic Dermatology Conference
📅 October 26–28, 2026
📍 Boston & Online
🔗 https://globaldermatologyconference.com/
🔗 https://globaldermatologyconference.com/register
🔗 https://globaldermatologyconference.com/abstract-submission
📩 dermatology@mathewsconference.com
📞 +1 (312) 462-4448
💬 +1 (424) 377 0967
No comments:
Post a Comment